EA199800176A1 - Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов - Google Patents

Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов

Info

Publication number
EA199800176A1
EA199800176A1 EA199800176A EA199800176A EA199800176A1 EA 199800176 A1 EA199800176 A1 EA 199800176A1 EA 199800176 A EA199800176 A EA 199800176A EA 199800176 A EA199800176 A EA 199800176A EA 199800176 A1 EA199800176 A1 EA 199800176A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
medicament
manufacture
acid derivatives
sulfamic acid
Prior art date
Application number
EA199800176A
Other languages
English (en)
Other versions
EA002435B1 (ru
Inventor
Брайен Роберт Краузе
Original Assignee
Варнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Варнер-Ламберт Компани filed Critical Варнер-Ламберт Компани
Publication of EA199800176A1 publication Critical patent/EA199800176A1/ru
Publication of EA002435B1 publication Critical patent/EA002435B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Настоящее изобретение относится к новой области применения в качестве лекарственных средств соединений формулы Iгде Х и Y означают атомы кислорода, серы и группу (CR'R"), в которой n означает число от 1 до 4, R означает атом водорода, алкильную или бензильную группу, Rи Rозначают фенильную или замещенную фенильную группу, нафтильную или замещенную нафтильную группу, арилалкильную группу, алкильную цепь, адамантильную или циклоалкильную группу. Их применяют для терапии таких заболеваний сосудов мозга, как удар, заболевания периферических сосудов и рестеноз.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800176A 1995-08-04 1996-07-08 Способ снижения уровня липопротеина (а) в сыворотке или в плазме крови млекопитающих EA002435B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (2)

Publication Number Publication Date
EA199800176A1 true EA199800176A1 (ru) 1998-10-29
EA002435B1 EA002435B1 (ru) 2002-04-25

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800176A EA002435B1 (ru) 1995-08-04 1996-07-08 Способ снижения уровня липопротеина (а) в сыворотке или в плазме крови млекопитающих

Country Status (27)

Country Link
US (1) US6117909A (ru)
EP (1) EP0841913B1 (ru)
JP (1) JPH11510184A (ru)
KR (1) KR19990036127A (ru)
CN (1) CN1192140A (ru)
AT (1) ATE232097T1 (ru)
AU (1) AU716255B2 (ru)
BG (1) BG63863B1 (ru)
CA (1) CA2221729A1 (ru)
CZ (1) CZ26198A3 (ru)
DE (1) DE69626118T2 (ru)
DK (1) DK0841913T3 (ru)
EA (1) EA002435B1 (ru)
EE (1) EE9800037A (ru)
ES (1) ES2191762T3 (ru)
GE (1) GEP20012511B (ru)
HR (1) HRP960341A2 (ru)
HU (1) HUP9900668A3 (ru)
IL (1) IL122247A0 (ru)
NO (1) NO980466L (ru)
NZ (1) NZ312571A (ru)
PL (1) PL185943B1 (ru)
PT (1) PT841913E (ru)
SK (1) SK12598A3 (ru)
UA (1) UA46030C2 (ru)
WO (1) WO1997005868A1 (ru)
ZA (1) ZA966617B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
SK502001A3 (en) * 1998-07-21 2002-06-04 Warner Lambert Co Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
PL355148A1 (en) * 1999-11-05 2004-04-05 Warner-Lambert Company Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
EP3709986B1 (en) 2017-11-14 2023-11-01 Merck Sharp & Dohme LLC Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
MX2020004930A (es) 2017-11-14 2020-08-27 Merck Sharp & Dohme Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido).

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
DK0555351T3 (da) * 1990-10-30 1995-06-06 Warner Lambert Co Oxysulfonylcarbamater
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
HUP9900668A2 (hu) 1999-06-28
NZ312571A (en) 2000-07-28
EP0841913B1 (en) 2003-02-05
EA002435B1 (ru) 2002-04-25
CN1192140A (zh) 1998-09-02
DK0841913T3 (da) 2003-05-05
CZ26198A3 (cs) 1998-07-15
EE9800037A (et) 1998-08-17
PL185943B1 (pl) 2003-09-30
BG102222A (en) 1998-09-30
DE69626118D1 (de) 2003-03-13
ES2191762T3 (es) 2003-09-16
UA46030C2 (uk) 2002-05-15
GEP20012511B (en) 2001-08-27
EP0841913A1 (en) 1998-05-20
BG63863B1 (bg) 2003-04-30
ATE232097T1 (de) 2003-02-15
ZA966617B (en) 1997-02-18
KR19990036127A (ko) 1999-05-25
WO1997005868A1 (en) 1997-02-20
PT841913E (pt) 2003-06-30
NO980466D0 (no) 1998-02-03
PL324908A1 (en) 1998-06-22
NO980466L (no) 1998-02-03
SK12598A3 (en) 1999-02-11
AU716255B2 (en) 2000-02-24
HRP960341A2 (en) 1998-02-28
US6117909A (en) 2000-09-12
CA2221729A1 (en) 1997-02-20
DE69626118T2 (de) 2003-11-27
IL122247A0 (en) 1998-04-05
HUP9900668A3 (en) 2000-08-28
JPH11510184A (ja) 1999-09-07
AU6454196A (en) 1997-03-05

Similar Documents

Publication Publication Date Title
ES2133163T3 (es) Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos.
NO843836L (no) Terapeutisk aktive sulfamatderivater
DE69500660T2 (de) Ophthalmische Zusammensetzung enthaltend ein 1,5-Benzoxathiepin-Derivat zur Behandlung von Glaukoma
FR2809396B1 (fr) Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
PA8477001A1 (es) Inhibidores no peptidilicos de la union a las celulas dependientes de la vla-4 utiles en el tratamiento de enfermedades inflamatorias autoinmunes y respiratorias
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
NO942372L (no) Propensyrederivater
EA199800176A1 (ru) Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов
DE58904143D1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE99934T1 (de) Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
DE69518706T2 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69421457T2 (de) Verwendung von N-(Pyridinyl)-1H-Indol-1-Aminen zur Herstellung eines Medikamentes zur Behandlung von zwangsneurotischen Erkrankungen
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
ATE191458T1 (de) Benzol-derivate
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
SE9401965D0 (sv) New compounds
KR950017956A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도
TH25930A (th) กรรมวิธีการเตรียม ซับสทิทิวเทด เบนซีนซัลโฟนิล-ยูเรีย-ไธโอยูเรีย การใช้สารดังกล่าวเป็นยาหรือใช้รักษาโรค และยาซึ่งมีสารดังกล่าว
TH7867EX (th) อนุพันธ์ 1, 5 -เบนโซไธอาเซพีน , การเตรียมสารและการใช้สารในการรักษาความผิดปกติเกี่ยวกับหัวใจ
TH33845A (ru)
TH25930B (th) กรรมวิธีการเตรียม ซับสทิทิวเทด เบนซีนซัลโฟนิล-ยูเรีย-ไธโอยูเรีย การใช้สารดังกล่าวเป็นยาหรือใช้รักษาโรค และยาซึ่งมีสารดังกล่าว

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU